High-speed spectrophotometer, 6/14
June 2014—QIAxpert from Qiagen is a high-speed UV/VIS spectrophotometer that enables laboratories to assess the quality and quantity of nucleic acids in up to 16 samples within just two minutes.
Webinars and Sponsored Roundtables — Register Now
Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
Semiautomated slide staining system, 6/14
June 2014—Siemens Healthcare launched the Hematek 3000 System, a semiautomated slide staining system that can stain up to 60 slides per hour.
Pressure-activated safety heel stick for infants, 6/14
June 2014—PlatinumCode added pediatric pressure-activated safety heel stick devices to its lineup. The devices come in four sizes and colors, with a range of blade depths.
ELISA kit for Alzheimer disease, 6/14
June 2014—Enzo’s quantitative, high-sensitivity ELISA kit for Alzheimer research enables identification and quantification of APP ∆C31.
High-performance rotors, 6/14
June 2014—Designed for applications that use common, disposable conical tubes, JA-14.50 rotors from Beckman Coulter extend the applications and flexibility of the company’s Avanti centrifuges.
3D tumor-stroma model for NSCLC, 6/14
June 2014—InSphero, working with researchers at the Medical University Innsbruck in Tyrol, Austria, published a study highlighting development of a novel 3D cell culture model for non-small cell lung cancer.
Software enhancements, 6/14
June 2014—AccuCore released AccuPathology 5.0, which includes enhancements in direct support of CoPath, PowerPath, Millennium, and AP Easy LIS. The Lab Equipment module now has optional wireless wi-fi logging to eliminate manual recording of temperatures and humidity levels and includes alerts.
Leica joins GHX Exchange, 6/14
June 2014—Leica Biosystems joined the GHX electronic trading exchange for U.S. customers. The GHX Exchange enables provider organizations to send their electronic data interchange (EDI) transactions through a single connection as opposed to multiple point-to-point EDI connections, thus allowing Leica’s customers to view their transactions and address discrepancies in real time.
epMotion for TruSeq, 6/14
June 2014—Eppendorf announced the epMotion automation method for Illumina’s TruSeq Stranded Total RNA library preparation kit for next-generation sequencing as “Illumina Qualified.”
HTG Molecular Diagnostics and OvaGene Oncology partner, 6/14
June 2014—HTG Molecular Diagnostics and OvaGene Oncology entered a manufacturing supply agreement in which OvaGene will design and develop its proprietary gene expression assays on HTG’s fully automated, extraction-free Edge Platform.